(Q37581342)

21 August 2017

1 reference

title

Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer (English)

1 reference

21 August 2017

0 references

1 reference

Viallet J

1

1 reference

21 August 2017

Minna JD

series ordinal

2

1 reference

21 August 2017

publication date

1 March 1990

1 reference

American Journal of Respiratory Cell and Molecular Biology

21 August 2017

published in

1 reference

21 August 2017

volume

2

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

225-232

1 reference

Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Gastrin-releasing peptide (GRP, mammalian bombesin) in the pathogenesis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

The molecular genetics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Human retinoblastoma susceptibility gene: cloning, identification, and sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Inactivation of the retinoblastoma susceptibility gene in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Allelotype of colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

c-K-ras codon 12 GGT-CGT point mutation. An infrequent event in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Genetic predisposition to human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

N-myc can cooperate with ras to transform normal cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

L-myc cooperates with ras to transform primary rat embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

The myc oncogene: its role in transformation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Nucleotide sequence of the human N-myc gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

AP1, a composite transcription factor implicated in abnormal growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

A nonrandom chromosomal abnormality, del 3p(14–23), in human small cell lung cancer (SCLC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

3p deletion and small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Genetics and smoking-associated cancers. A study of 485 families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Familial aggregation of lung cancer among hospital patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Non-ocular cancer in relatives of retinoblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Correlation of DNA adduct levels in human lung with cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Loss of a Harvey ras allele in sporadic Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB%2F2.3.225

21 January 2018

Identifiers

DOI

10.1165/AJRCMB/2.3.225

1 reference

21 August 2017

1 reference